Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

Conditions:   Pulmonary Embolism;   Venous Thromboembolism;   Deep Vein Thrombosis
Intervention:  
Sponsor:   Volcano Corporation
Not yet recruiting - verified April 2015

Apixaban for Treatment of Embolic Stroke of Undetermined Source

Condition:   Embolic Stroke
Interventions:   Drug: Apixaban;   Drug: Aspirin
Sponsor:   University Hospital Tuebingen
Not yet recruiting - verified April 2015

Pulmonary Embolism Diagnosis: Ultrasound Wells Score vs Traditional Wells Score

Condition:   Pulmonary Embolism
Intervention:  
Sponsor:   Azienda Ospedaliero-Universitaria Careggi
Recruiting - verified April 2015

Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)

Conditions:   Wounds and Injuries;   Acute Coagulopathy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsors:   National Trauma Research Institute;   National Health and Medical Research Council, Australia
Recruiting - verified April 2015

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

Conditions:   Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE)
Intervention:  
Sponsor:   Johannes Gutenberg University Mainz
Recruiting - verified April 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified April 2015

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified April 2015

STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial

Conditions:   Intracerebral Haemorrhage;   Stroke
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Neuroscience Trials Australia
Recruiting - verified September 2014

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Conditions:   Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:  
Sponsors:   Ottawa Hospital Research Institute;   Heart and Stroke Foundation of Ontario
Active, not recruiting - verified April 2015

Role of Cerebral Oximetry In Reducing Delirium After Complex Cardiac Surgery

Condition:   Cardiac Disease
Interventions:   Device: Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter);   Other: An alarm threshold at 75% of the baseline rSO2 value
Sponsor:   University Health Network, Toronto
Active, not recruiting - verified April 2015

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2015

Development of Computer-aided Detection and Diagnosis From Imaging Techniques

Condition:   Cancer
Intervention:  
Sponsor:   National Institutes of Health Clinical Center (CC)
Completed - verified April 2015

Odiparcil For The Prevention Of Venous Thromboembolism

Conditions:   Fibrillation, Atrial;   Deep Vein Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Interventions:   Drug: Odiparcil;   Drug: Warfarin;   Drug: Coumadin
Sponsor:   GlaxoSmithKline
Completed - verified April 2015

Get CardioSmart

You're Invited